Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fortress Biotech Inc. buy melinda

Start price
€1.81
30.08.18 / 50%
Target price
€3.61
17.12.18
Performance (%)
-48.76%
End price
€0.93
17.12.18
Summary
This prediction ended on 17.12.18 with a price of €0.93. Massive losses of -48.76% were the result for the BUY prediction by melinda. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Fortress Biotech Inc. - - - -
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

Comments by melinda for this prediction

In the thread Fortress Biotech Inc. diskutieren
Prediction Buy
Perf. (%) -48.76%
Target price 3.608
Change
Ends at 17.12.18

SecteurProduits pharmaceutiques Agenda 08/11 Publication de résultats



Métier
Logo Fortress Biotech Inc
Develops novel immunotherapy biologic agents

Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products.

It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National.

The National segment consists of National Holdings Corporation, an independent brokerage company.

The company was founded on June 28, 2006 in and is headquartered in New York, NY.

Nombre d'employés : 68 personnes.



Prediction Buy
Perf. (%) -48.76%
Target price 3.608
Change
Ends at 17.12.18

(Vom Mitglied beendet)

Stopped prediction by melinda for Fortress Biotech Inc.

buy
Fortress Biotech Inc.

Start price
Target price
Perf. (%)
€1.22
29.09.19
-
04.11.21
154.10%
05.11.21